Related Experiment Video
Updated: Jun 16, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
Multimodal regulation of E2F1 gene expression by progestins.
Hilary E Wade1, Sakiko Kobayashi, Matthew L Eaton
1Duke University Medical Center, Department of Pharmacology and Cancer Biology, Durham, NC 27710, USA.
Progesterone receptor (PR) regulates E2F1 expression through direct and indirect pathways in breast cancer cells. This involves PR binding to enhancers and activating a positive feedback loop for E2F1 transcription.
Area of Science:
- Endocrinology
- Molecular Biology
- Genomics
Background:
- Progesterone receptor (PR) plays a crucial role in breast cancer development and progression.
- PR target genes are implicated in cell proliferation and cancer signaling pathways.
- E2F transcription factors are key regulators of cell cycle progression.
Purpose of the Study:
- To investigate the regulatory mechanisms of E2F1 expression by progesterone receptor (PR) in breast cancer cells.
- To elucidate the direct and indirect pathways involved in PR-mediated E2F1 upregulation.
- To identify novel regulatory interactions between PR, E2F1, and other transcription factors.
Main Methods:
- Analysis of mRNA expression in T47D breast cancer cells treated with synthetic progestin R5020.
- Chromatin immunoprecipitation (ChIP) assays to assess PR binding to E2F1 gene regulatory elements.
- Cycloheximide treatment to evaluate the role of protein synthesis in PR-mediated E2F1 regulation.
- Western blot analysis to detect Rb phosphorylation.
- Assessment of E2F1 recruitment to its own promoter.
Main Results:
- PR directly upregulates E2F1 expression by binding to enhancer elements.
- Indirect PR regulation of E2F1 involves increased Rb hyperphosphorylation and E2F1 promoter recruitment, creating a positive feedback loop.
- PR-induced Krüppel-like factor 15 (KLF15) is essential for maximal progestin-driven E2F1 expression.
- A subset of PR target genes is enriched for E2F binding sites.
Conclusions:
- PR employs a multimodal regulatory strategy to control E2F1 expression in breast cancer cells.
- The interplay between direct PR action, Rb pathway activation, and KLF15 induction represents a novel mechanism for gene regulation.
- Understanding these pathways may offer new therapeutic targets for PR-positive breast cancers.
Related Concept Videos
Regulation of Expression at Multiple Steps
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Negative Regulator Molecules
Mitogens and the Cell Cycle
Regulation of Nuclear Protein Sorting

